Chi Health At Home - Grand Island | |
2116 W Faidley Ave, Grand Island, Nebraska 68803 | |
(308) 398-2600 | |
Name | Chi Health At Home - Grand Island |
---|---|
Location | 2116 W Faidley Ave, Grand Island, Nebraska |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 287005 |
Ownership Type | Voluntary Non Profit - Religious Affiliation |
Service Area Zip Codes | 68801, 68802, 68803, 68810, 68812, 68818, 68824, 68826, 68827, 68831, 68832, 68835, 68836, 68840, 68841, 68844, 68845, 68847, 68848, 68850, 68852, 68854, 68858, 68863, 68865, 68866, 68869, 68870, 68872, 68873, 68876, 68883, 68901, 68924, 68949, 68955, 68959, 68973, 68982 |
NPI Number | 1437495736 |
Organization Name | CHI NATIONAL HOME CARE, LLC |
Doing Business As | CHI HEALTH AT HOME - GRAND ISLAND |
Address | 2116 W Faidley Ave, Grand Island, NE 68803 |
Phone Number | 308-398-2600 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
NPI Number | 1619948601 |
Organization Name | SAINT FRANCIS MEDICAL CENTER |
Address | 2116 W Faidley Ave, Grand Island, NE 68803 |
Phone Number | 308-398-2600 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
Quality Rating: |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.7 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 98.7 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 91.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 85.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.2 | 96.4 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 83.1 | 79.6 |
How often patients got better at getting in and out of bed | 84.4 | 81.1 |
How often patients got better at bathing | 81.8 | 82.3 |
How often patients’ breathing improved | 84 | 82.8 |
How often patients’ wounds improved or healed after an operation | 89.6 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 75.1 | 75 |
How often home health patients had to be admitted to the hospital | 14.6 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 93.6 | 94 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
The patient survey data of Chi Health At Home - Grand Island is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 86 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 79 | 78 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office (EPO) has granted European patent No. EP1212055 entitled "Neurotherapeutic compositions comprising a beta-lactam compound."
A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).
A study by researchers from the Imperial College London provides specific evidence of an association between averaged exposure during 2014-2018 to nitrogen dioxide (NO2) and COVID-19 mortality, while the role of atmospheric particulate matter (PM2.5) remains much more controversial. The paper is currently available on the medRxiv preprint server.
There may be a way around the harsh skin toxicity associated with a widely used cancer drug, according to a study published online this week in Cancer Biology and Therapy by researchers from City of Hope and the Kimmel Cancer at Jefferson.
SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.
› Verified 2 days ago
Chi Health At Home - Grand Island Location: 2116 W Faidley Ave, Grand Island, Nebraska 68803 Ratings: Phone: (308) 398-2600 | |
Good Samaritan Society Home Health Location: 3415 W State Street, Ste B, Grand Island, Nebraska 68803 Ratings: Phone: (308) 382-4054 |